POLY(D-GLU, D-LYS) HYDROBROMIDE
Modify Date: 2024-02-25 13:34:27
POLY(D-GLU, D-LYS) HYDROBROMIDE structure
|
Common Name | POLY(D-GLU, D-LYS) HYDROBROMIDE | ||
|---|---|---|---|---|
| CAS Number | 119039-80-4 | Molecular Weight | 306.271 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 579.8±60.0 °C at 760 mmHg | |
| Molecular Formula | C13H12F2N6O | Melting Point | N/A | |
| MSDS | USA | Flash Point | 304.4±32.9 °C | |
| Name | Fluconazole |
|---|---|
| Synonym | More Synonyms |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 579.8±60.0 °C at 760 mmHg |
| Molecular Formula | C13H12F2N6O |
| Molecular Weight | 306.271 |
| Flash Point | 304.4±32.9 °C |
| Exact Mass | 306.104065 |
| LogP | 0.50 |
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
| Index of Refraction | 1.663 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
|
Immunologic responses to conjugates of antigen E in patients with ragweed hay fever.
J. Allergy Clin. Immunol. 73 , 782-789, (1984) Allergens conjugated with several simple repeating polymers have reduced allergenicity in man, but large doses retain the ability to suppress ongoing allergen-specific IgE synthesis in strains of high... |
|
|
Immunological tolerance to allergenic protein determinants: a therapeutic approach for selective inhibition of IgE antibody production.
Proc. Natl. Acad. Sci. U. S. A. 76 , 1430-1434, (1979) Administration of stable conjugates prepared by coupling protein antigens such as ovalbumin or antigen E of ragweed extract to the synthetic random copolymer of D-glutamic acid and D-lysine (D-GL) is ... |
|
|
Relation between optical configuration and immunogenicity of synthetic polypeptides.
Biochem. J. 96 , 577-582, (1965) 1. Three random linear copolymers composed of two or three of the amino acids d-tyrosine, d-glutamic acid, d-alanine and d-lysine, and a branched multichain copolymer with a poly-d-lysine backbone and... |
| 1H-1,2,4-Triazole-1-ethanol, α-(2,4-difluorophenyl)-α-(1H-1,2,4-triazol-1-ylmethyl)- |
| 2-(2,4-Difluorphenyl)-1,3-di-1H-1,2,4-triazol-1-ylpropan-2-ol |
| a-(2,4-Difluorophenyl)-a-(1H-1,2,4-triazol-1-ylmethyl)-1H-1,2,4-triazole-1-ethanol |
| 2-(2,4-Difluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)-2-propanol |
| 2-(2,4-difluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol |
| Fluconazole for peak identification |
| Fluconazole |
| EINECS 200-659-6 |
| 2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol |
| Apo Fluconazole |
| 1H-1,2,4-triazole-1-ethanol, a-(2,4-difluorophenyl)-a-(1H-1,2,4-triazol-1-ylmethyl)- |
| α-(2,4-Difluorophenyl)-α-(1H-1,2,4-triazol-1-ylmethyl)-1H-1,2,4-triazole-1-ethanol |
| Zonal |
| 2-(2,4-Difluorphenyl)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol |
| Apo-Fluconazole |
| Diflazon |
| 2,4-Difluoro-a,a-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl Alcohol |
| Diflucan |
| MFCD00274549 |
| MFCD11848677 |
| Flusol |
| Flucostat |